- Home
- AVAV vs QGEN Comparison
AVAV vs QGEN Comparison
Compare AVAV & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVAV
- QGEN
- Stock Information
- Founded
- AVAV 1971
- QGEN 1986
- Country
- AVAV United States
- QGEN Netherlands
- Employees
- AVAV N/A
- QGEN N/A
- Industry
- AVAV Aerospace
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AVAV Industrials
- QGEN Health Care
- Exchange
- AVAV Nasdaq
- QGEN Nasdaq
- Market Cap
- AVAV 12.1B
- QGEN 10.1B
- IPO Year
- AVAV 2007
- QGEN 1996
- Fundamental
- Price
- AVAV $407.52
- QGEN $47.79
- Analyst Decision
- AVAV Strong Buy
- QGEN Buy
- Analyst Count
- AVAV 13
- QGEN 8
- Target Price
- AVAV $349.23
- QGEN $51.01
- AVG Volume (30 Days)
- AVAV 1.4M
- QGEN 1.1M
- Earning Date
- AVAV 09-09-2025
- QGEN 11-05-2025
- Dividend Yield
- AVAV N/A
- QGEN 3.23%
- EPS Growth
- AVAV N/A
- QGEN 405.09
- EPS
- AVAV N/A
- QGEN 1.69
- Revenue
- AVAV $1,085,820,000.00
- QGEN $2,040,067,000.00
- Revenue This Year
- AVAV $148.47
- QGEN $7.37
- Revenue Next Year
- AVAV $16.72
- QGEN $5.70
- P/E Ratio
- AVAV N/A
- QGEN $27.64
- Revenue Growth
- AVAV 44.03
- QGEN 5.15
- 52 Week Low
- AVAV $102.25
- QGEN $37.63
- 52 Week High
- AVAV $410.30
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- AVAV 89.56
- QGEN 56.92
- Support Level
- AVAV $303.72
- QGEN $43.74
- Resistance Level
- AVAV $317.11
- QGEN $47.16
- Average True Range (ATR)
- AVAV 14.38
- QGEN 0.62
- MACD
- AVAV 10.50
- QGEN 0.36
- Stochastic Oscillator
- AVAV 97.19
- QGEN 96.49
About AVAV AeroVironment Inc.
AeroVironment Inc operates under a single business segment in which it supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky. The company is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploy autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).